BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Bioclinica Appoints David Herron as CEO

  With more than 10 years’ of experience at Bioclinica, David Herron has led the company’s Medical Imaging business to great success

  December 1, 2017

   · 

  3 min read
• Vilacto Bio Issues Statement About Promotional Activity Concerning Its Common Stock

  The Company is not affiliated in any way with the authors of the promotional activity identified by OTC Markets.

  December 1, 2017

   · 

  3 min read
• Catalyst Pharmaceuticals Announces Closing of Previously Announced Public Offering - Dec. 1, 2017

  Piper Jaffray & Co. acted as the lead bookrunner. SunTrust Robinson Humphrey, Inc. also acted as a bookrunner.

  December 1, 2017

   · 

  3 min read
• Policy

  FDA Approval of Mylan’s Heparin Sodium Injection Continues to Demonstrate Mylan’s Deep Expertise in Developing Complex Products

  Mylan today announced it has received final approval from the FDA for its ANDAs for Heparin Sodium Injection USP, 1,000 USP/mL, 5,000 USP/mL, 10,000 USP/mL, and 20,000 USP/mL, all of which are packaged in multi-dose vials.

  December 1, 2017

   · 

  5 min read
• Southern Implants North America Launches New Implant Designs

  SINA expects to significantly accelerate its growth in the North American market driven by the new opportunities these products create.

  December 1, 2017

   · 

  2 min read
• Business

  Mauna Kea Technologies Renews Its Equity Financing Facility With Kepler Cheuvreux Building to Support Its Development

  Mauna Kea Technologies announces the implementation of a new equity financing facility with Kepler Cheuvreux building on the success of the former one which was announced on October 6, 2017 and enabled the company to raise €7.7 million.

  December 1, 2017

   · 

  3 min read
• Business

  Pfizer Enters into Agreement to Develop and Commercialize CRESEMBA (isavuconazole) in China and Asia Pacific Region

  Pfizer and Basilea Pharmaceutica announced they have entered into an agreement whereby Pfizer will be granted the exclusive development and commercialization rights in China and several countries in the Asia Pacific region to CRESEMBA (isavuconazole).

  December 1, 2017

   · 

  9 min read
• BioMidwest

  RNA Release: 3-D-Printed Prosthetic Implants Could Improve Treatment for Hearing Loss

  Researchers using CT scans and 3-D printing have created accurate, custom-designed prosthetic replacements for damaged parts of the middle ear, according to a study being presented today at the annual meeting of the RSNA.

  December 1, 2017

   · 

  3 min read
• Business

  Evotec Receives Clinical Milestone As Part of Its Discovery Alliance With Boehringer Ingelheim

  Evotec AG announced today that it has achieved a clinical milestone under its drug discovery alliance with Boehringer Ingelheim triggering revenues of EUR 2.00 m to Evotec.

  December 1, 2017

   · 

  4 min read
• Policy

  Dr. Reddy’s Announces Approval of Impoyz (clobetasol propionate) Cream, 0.025% First-Cycle NDA Approval

  This approval is another example of the deep and broad capabilities within the Proprietary Products business unit at Dr. Reddy’s.

  December 1, 2017

   · 

  5 min read